Searching for smart, safe news you can TRUST?
Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
J. Scott Applewhite / AP
Food and Drug Administration commissioner Scott Gottlieb says he's figured out a few things the FDA can do to help control rising drug prices, even though that issue isn't specifically part of the agency's mission. Business Insider has a good rundown of what he proposed at yesterday's House subcommittee hearing on FDA funding for next year:
- Keep drug companies from gaming the system to win more time without competition.
- Help get complex generic drugs to market more quickly.
- Cut the backlog of generic drugs waiting for approval.
Why it matters: Republicans are counting on Gottlieb to help them achieve their goal: bring down drug prices through market competition, not through government intervention.